Skip to main content
Top
Published in: AIDS and Behavior 1/2017

01-07-2017 | Original Paper

The Role of Civil Society Organizations in Monitoring the Global AIDS Response

Authors: Julia Smith, Christoforos Mallouris, Kelley Lee, Tobias Alfvén

Published in: AIDS and Behavior | Special Issue 1/2017

Login to get access

Abstract

Civil society organizations (CSOs) are recognized as playing an exceptional role in the global AIDS response. However, there is little detailed research to date on how they contribute to specific governance functions. This article uses Haas’ framework on global governance functions to map CSO’s participation in the monitoring of global commitments to the AIDS response by institutions and states. Drawing on key informant interviews and primary documents, it focuses specifically on CSO participation in Global AIDS Response Progress Reporting and in Global Fund to Fight AIDS, Tuberculosis and Malaria processes. It argues that the AIDS response is unique within global health governance, in that CSOs fulfill both formal and informal monitoring functions, and considers the strengths and weaknesses of these contributions. It concludes that future global health governance arrangements should include provisions and resources for monitoring by CSOs because their participation creates more inclusive global health governance and contributes to strengthening commitments to human rights.
Footnotes
1
In total 173 submitted the NCPI in 2012 and in 2014 117 countries submitted the complete NCPI (including the CSO section), and 43 countries in Europe and Central Asia submitted responses to a shorter version, the so called Dublin Declaration questionnaire, not including all these questions.
 
Literature
1.
go back to reference Buse K, Blackshaw R, Ndayisaba M. Zeroing in on AIDS and global health post-2015. Glob Health. 2012;8(1):42.CrossRef Buse K, Blackshaw R, Ndayisaba M. Zeroing in on AIDS and global health post-2015. Glob Health. 2012;8(1):42.CrossRef
2.
go back to reference Doyle C, Patel P. Civil society organisations and global health initiatives: problems of legitimacy. Soc Sci Med. 2008;66(9):1928–38.CrossRefPubMed Doyle C, Patel P. Civil society organisations and global health initiatives: problems of legitimacy. Soc Sci Med. 2008;66(9):1928–38.CrossRefPubMed
3.
go back to reference Haas P. Is there a global governance deficit and what should be done about it?. Geneva: Ecologic; 2003. Haas P. Is there a global governance deficit and what should be done about it?. Geneva: Ecologic; 2003.
4.
go back to reference Lee K. Civil society organizations and the functions of global health governance: what role within intergovernmental organizations? Glob Health Gov. 2010;3(2):1–20. Lee K. Civil society organizations and the functions of global health governance: what role within intergovernmental organizations? Glob Health Gov. 2010;3(2):1–20.
5.
go back to reference United Nations. Declaration of Commitment on HIV/AIDS. United Nations General Assembly Special Session on HIV/AIDS 25–27 June 2001. United Nations. New York. United Nations. Declaration of Commitment on HIV/AIDS. United Nations General Assembly Special Session on HIV/AIDS 25–27 June 2001. United Nations. New York.
6.
go back to reference UNAIDS representative 1. Interviewed by Smith J. 2013. UNAIDS representative 1. Interviewed by Smith J. 2013.
7.
go back to reference CSO representative 4. Interviewed by Smith J. 2013. CSO representative 4. Interviewed by Smith J. 2013.
8.
go back to reference UNAIDS. United Nations General Assembly Special Session on HIV/AIDS: monitoring the Declaration of Commitment on HIV/AIDS. Guidelines on construction of core indicators. UNAIDS: Geneva; 2013. UNAIDS. United Nations General Assembly Special Session on HIV/AIDS: monitoring the Declaration of Commitment on HIV/AIDS. Guidelines on construction of core indicators. UNAIDS: Geneva; 2013.
9.
go back to reference NCPI country reports submitted to UNAIDS 2012. NCPI country reports submitted to UNAIDS 2012.
10.
go back to reference NCPI country reports submitted to UNAIDS 2014. NCPI country reports submitted to UNAIDS 2014.
11.
go back to reference UNAIDS representative 2. Interviewed by Mallouris C. 2015. UNAIDS representative 2. Interviewed by Mallouris C. 2015.
12.
go back to reference CSO representative 1. Interviewed by Mallouris C. 2015. CSO representative 1. Interviewed by Mallouris C. 2015.
13.
go back to reference CSO representative 2. Interviewed by Mallouris C. 2015. CSO representative 2. Interviewed by Mallouris C. 2015.
14.
go back to reference CSO representative 3. Interviewed by Mallouris C. 2015. CSO representative 3. Interviewed by Mallouris C. 2015.
15.
go back to reference UNAIDS. Global aids response progress reporting 2015, construction of core indicators for monitoring the 2011 United Nations Political Declaration on HIV and AIDS. Geneva: UNAIDS; 2014. UNAIDS. Global aids response progress reporting 2015, construction of core indicators for monitoring the 2011 United Nations Political Declaration on HIV and AIDS. Geneva: UNAIDS; 2014.
19.
go back to reference UNAIDS. Shadow reports received. Geneva: UNAIDS; 2012. UNAIDS. Shadow reports received. Geneva: UNAIDS; 2012.
20.
go back to reference UNAIDS. Shadow reports received. Geneve:UNAIDS; 2014. UNAIDS. Shadow reports received. Geneve:UNAIDS; 2014.
22.
go back to reference Center Fremont. Global fund partnership forum 2011: an independent evaluation. New York: Fremont Center; 2011. Center Fremont. Global fund partnership forum 2011: an independent evaluation. New York: Fremont Center; 2011.
23.
go back to reference GFATM. A strategy framework for the global fund 2012–2016: draft revisions 1.1 and 1.2. Geneva; 2011. (emphasis added). GFATM. A strategy framework for the global fund 2012–2016: draft revisions 1.1 and 1.2. Geneva; 2011. (emphasis added).
24.
go back to reference GFATM representative 1. Interviewed by Smith J. 2013. GFATM representative 1. Interviewed by Smith J. 2013.
25.
go back to reference MACRO. The five-year evaluation of the global fund to fight AIDS, tuberculosis, and malaria synthesis of study areas 1, 2 and 3. Geneva: GFATM; 2009. MACRO. The five-year evaluation of the global fund to fight AIDS, tuberculosis, and malaria synthesis of study areas 1, 2 and 3. Geneva: GFATM; 2009.
26.
go back to reference GFATM representative 2. Interviewed by Smith J. 2013. GFATM representative 2. Interviewed by Smith J. 2013.
27.
go back to reference Global ICW. Governance manual. Buenos Aires: International Community of Women Living With HIV/AIDS; 2012. Global ICW. Governance manual. Buenos Aires: International Community of Women Living With HIV/AIDS; 2012.
28.
go back to reference CSO representative 5. Interviewed by Smith J. 2013. CSO representative 5. Interviewed by Smith J. 2013.
29.
go back to reference Taylor A, Alfven T, Hougendobler D, Tanaka S, Buse K. Leveraging nonbinding instruments for global health governance: reflections from the global AIDS reporting mechanism for WHO reform. Public Health. 2014;128(2):151–60.CrossRefPubMed Taylor A, Alfven T, Hougendobler D, Tanaka S, Buse K. Leveraging nonbinding instruments for global health governance: reflections from the global AIDS reporting mechanism for WHO reform. Public Health. 2014;128(2):151–60.CrossRefPubMed
Metadata
Title
The Role of Civil Society Organizations in Monitoring the Global AIDS Response
Authors
Julia Smith
Christoforos Mallouris
Kelley Lee
Tobias Alfvén
Publication date
01-07-2017
Publisher
Springer US
Published in
AIDS and Behavior / Issue Special Issue 1/2017
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-016-1579-3

Other articles of this Special Issue 1/2017

AIDS and Behavior 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.